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OBJECTIVE: Two percent of all children and 4% of all adoles-
cents in the United States have been diagnosed with Major
Depressive Disorder (MDD). Unfortunately, many children and
adolescents who have MDD never receive proper treatment. Of
those who do receive treatment, antidepressants are commonly
utilized. In October, 2004 the US Food and Drug Administration
(FDA) issued a Public Health Advisory to warn that increased
risk of suicidal thoughts and behaviors may be associated with
the use of antidepressant medications, including SSRIs, in chil-
dren and adolescents. Since this warning is based, in part, on 
the hypothesis that the use of SSRIs may increase the risk of 
suicidality (thoughts and behaviors), this review examines how
suicidality has been measured in randomized controlled trials
(RCTs) of SSRI use in children and adolescents with MDD.
METHODS: The tiered search strategy included RCTs published
between January 1, 1985 and October 31, 2004. Three electronic
bibliographic databases (Medline, PsycINFO, and Dissertation
Abstracts) and the Cochrane Libraries were searched for research
articles meeting the deﬁned inclusion criteria for children and
adolescents. RESULTS: Eight randomized controlled trials met
the inclusion criteria. All eight studies had a general recording
of adverse events, but only four utilized one or more formalized
measure(s) of suicidality. Two of the measures consisted of only
one item related to suicidal ideation, and not all measures used
had been previously validated. CONCLUSIONS: No consistent
methods for deﬁning or measuring suicidality were employed
across studies, even those used to rationalize the FDA warning.
Furthermore, when suicidality was measured, only a part of sui-
cidality was formally measured. Future research should utilize
consistent deﬁnitions and validated measurements of suicidality
so that the risks associated with SSRIs in children and adoles-
cents with MDD will be accurately understood and effectively
compared.
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OBJECTIVES: To compare and contrast the Exhaustive CHAID
classiﬁcation tree to forward stepwise LR in explaining the pre-
scribing of antidepressants in terms of identifying explanatory
variables and interaction effects, accuracy, sensitivity, speciﬁ-
city, and Receiver Operating Characteristic (ROC) analysis.
METHODS: Throughout 1997–2001, National Ambulatory
Medical Care Survey (NAMCS) data was used. The dependent
variable was the prescribing of antidepressants and the explana-
tory variables were 13 variables associated with the patient and
physician characteristics. The data was randomly divided by 7 :
3 for training set and test set. The training set was used to train
the Exhaustive CHAID and forward stepwise LR models and the
test set was used to evaluate the performance of both models.
RESULTS: About 6.7% of the 113,128 ofﬁce visits analyzed had
been prescribed at least 1 antidepressant. While the forward step-
wise LR resulted to all 13 explanatory variables as signiﬁcant,
the Exhaustive CHAID identiﬁed 11 explanatory variables and
3 interactions as signiﬁcantly associated with the prescribing of
antidepressants. The Pearson correlation of the predicted logits
from both models was 0.76492 (p < 0.001). At cut point of 0.5,
the classiﬁcation accuracy, sensitivity, and speciﬁcity of Exhaus-
tive CHAID were 0.95, 0.51, and 0.98 respectively, and were
0.95, 0.36, and 0.99 correspondingly for forward stepwise LR.
The area under the ROC curve of Exhaustive CHAID (0.8610)
slightly and signiﬁcantly outperformed that of forward stepwise
LR (0.8507). CONCLUSIONS: The performance of Exhaustive
CHAID was at least as comparable with forward stepwise LR.
In addition, Exhaustive CHAID has the capacity to automati-
cally detect interaction effects without having to specify a priori
the potential interaction terms. The Exhaustive CHAID produces
a more parsimonious model by using fewer variables to explain
the dependent variable. The resulting classiﬁcation tree also 
provides a visually informative structure on how variables are
selected into the model by their relative contributions.
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OBJECTIVES: Major depressive episodes (MDE) and anxiety
are associated with decreased health-related quality of life
(HRQL). The EQ-5D assesses ﬁve domains, including the single
domain of Anxiety/Depression. Thus, the EQ-5D may be limited
in differentiating among subjects with either or both of MDE
and anxiety disorders. Our objective was to determine the ability
of the EQ-5D to differentiate among persons with MDE or
anxiety alone or in combination, compared with neither.
METHODS: Data were collected in 2003 as part of the Alberta
Mental Health Survey and were obtained through random digit
dialing and computer assisted telephone interviews. MDE and
anxiety were deﬁned by DSM-IV using the Mini International
Neuropsychiatric Interview. HRQL was measured with the 
EQ-5D; responses on the Anxiety/Depression domain were
dichotomized to 1) no problem, or 2) moderate/extreme prob-
lems. Descriptive and multivariate analyses were used to examine
associations between EQ-5D scores and mental health diagnoses.
RESULTS: The average age of the sample (n = 5383) was 40.8
(12.1) years, 61% were female. The prevalence for diagnoses
(and proportion within each group reporting problems on the
Anxiety/Depression domain) were: MDE alone 2.6% (48.6%);
anxiety alone 11.3% (38.7%); MDE and anxiety 5.2% (80.8%);
and neither 80.9% (8.2%), respectively. Compared with subjects
with neither condition, after adjustment for socio-demographic
variables, mean EQ-Index and EQ-VAS scores were signiﬁcantly
lower for subjects with MDE and anxiety (0.70, 64.2), followed
by those with MDE alone (0.83, 70.8) and anxiety alone (0.84,
76.7). CONCLUSIONS: Respondents with MDE or anxiety
alone reported similar burden on the EQ-5D, overall and on the
Anxiety/Depression domain. Comorbid MDE and anxiety is
reﬂected in substantially lower EQ-5D scores. The EQ-5D per-
forms reasonably well as a measure of general mental health, but
more in-depth and speciﬁc measures would be required to iden-
tify and differentiate the impact of isolated mental health con-
ditions on HRQL.
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OBJECTIVES: Depression-free days (DFD) and quality-adjusted
days (QAD) are used to assess the overall effectiveness of anti-
depressants for patients with major depressive disorder (MDD).
Both metrics estimate utility based on fractions from scores on
the Hamilton Rating Scale for Depression (HAM-D). The objec-
tive of this study was to develop a new patient-preference
